Back to today’s briefing

Story perspectives

New LSD Analog Promises Neuropsychiatric Treatment Without Hallucinations

4/14/2025

42 5

Summary

Story summary

Researchers at UC Davis have unveiled JRT, a groundbreaking non-hallucinogenic analog of LSD that boosts neuroplasticity without the mind-bending effects. By enhancing dendritic spine and synapse density, JRT holds promise for treating schizophrenia and other neuropsychiatric disorders. This innovative compound was crafted by rearranging two atoms in LSD's structure, prioritizing safety and therapeutic benefits.

1 of 1

Story summary

Researchers at UC Davis have unveiled JRT, a groundbreaking non-hallucinogenic analog of LSD that boosts neuroplasticity without the mind-bending effects. By enhancing dendritic spine and synapse density, JRT holds promise for treating schizophrenia and other neuropsychiatric disorders. This innovative compound was crafted by rearranging two atoms in LSD's structure, prioritizing safety and therapeutic benefits.